Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dar Aldawa Dv/Iv | Amman | Healthcare | Pharmaceuticals | JOD 39.55M | 9.5x | 0.28 | JOD 1.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Consulting Group | Amman | Healthcare | Healthcare Providers & Services | JOD 35M | 18.1x | 0.32 | JOD 1.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hayat Phat | Amman | Healthcare | Pharmaceuticals | JOD 28.88M | 9.7x | 4.57 | JOD 3.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ibn Alhaytham H. | Amman | Healthcare | Healthcare Providers & Services | JOD 13.80M | 328.6x | 3.28 | JOD 0.69 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Philadelphia Pharma Industry | Amman | Healthcare | Pharmaceuticals | JOD 11.10M | 12.1x | 1.04 | JOD 1.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |